① China Tower's net profit increased by more than 10% in the first quarter. How was the revenue performance? ② The number of passengers carried by Cathay Pacific increased by 40% in March. What was the overall recovery situation in the first quarter?
Important announcements for Hong Kong stocks from Friday to the weekend are as follows:
Company news
$CHINA TOWER (00788.HK)$: Revenue for the first quarter was 23.974 billion yuan, up 3.3% year over year. Profit attributable to the company's shareholders was 2,784 billion yuan, an increase of 11.1% over the previous year.
$CHINA TELECOM (00728.HK)$: The number of mobile users in March was about 412 million, with a net increase of 1.91 million users in the month, and a cumulative net increase of 3.88 million users during the year.
$CHINA UNICOM (00762.HK)$: In March, the total number of “Big Connect” users reached about 1,028 million, the cumulative number of 5G package users reached about 269 million, and the cumulative number of IoT terminal connections reached about 528.5 million; the number of virtual private network service customers in the 5G industry was 1,030.
$CHINA UNICOM (00762.HK)$: Revenue for the first quarter was 99.496 billion yuan, up 2.3% year on year; net profit was 5.613 billion yuan, up 8.9% year on year.
$CATHAY PAC AIR (00293.HK)$: In March, it carried 1.8834 million passengers, up 42.4% year on year; passenger carrying rate fell 6.6 percentage points to 83.8%, increasing 55.7% year on year to 5.4018 million in the first quarter.
$KINTOR PHARMA-B (09939.HK)$: The GT20029 Chinese phase II clinical trial for male alopecia reached the main end.
$CANSINOBIO (06185.HK)$: The recombinant pneumococcal protein vaccine obtained positive initial phase I clinical results.
$KUAISHOU-W (01024.HK)$A total of 567.634 million restricted share units were granted.
$HUAYI TENCENT (00419.HK)$: and$GOLDSTREAM INV (01328.HK)$Establish a strategic cooperation framework agreement.
Buyback News
$DONGFENG GROUP (00489.HK)$: The controlling shareholder increased its H share holdings by 5.85 million shares.
$WEIMOB INC (02013.HK)$: It is proposed to place 277 million shares, with a net raise of approximately HK$308 million.
$HSBC HOLDINGS (00005.HK)$: HK$229 million was spent to repurchase 3.673,200 shares at a repurchase price of HK$61.80-62.75.
$HANG SENG BANK (00011.HK)$: Spend HK$57.2853 million to repurchase 600,000 shares at a repurchase price of HK$93.9-96.35.
$XIAOMI-W (01810.HK)$: Spend HK$475.58 million to repurchase 3 million shares at a repurchase price of HK$15.82-15.86.
$BEKE-W (02423.HK)$: Repurchase 1.782,700 shares at a cost of $7.495,900.
$CSPC PHARMA (01093.HK)$: Spend HK$345.693 million to repurchase 6 million shares at a repurchase price of HK$5.66-5.82.
$CK ASSET (01113.HK)$: Spend HK$21.632,500 to repurchase 700,000 shares at a repurchase price of HK$30.7-31.05.
$WUXI BIO (02269.HK)$: A repurchase of 1.57 million shares was spent at HK$199204 million, with a repurchase price of HK$12.62-12.80.
edit/ruby